Mirae Asset Global ETFs Holdings
STRO icon

Mirae Asset Global ETFs Holdings’s Sutro Biopharma STRO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,900
Closed -$31.9K – 3226
2025
Q1 		$31.9K Buy
4,900
+211
+4% +$3.32K ﹤0.01% 2920
2024
Q4 		$86.3K Buy
4,689
+206
+5% +$6.29K ﹤0.01% 2758
2024
Q3 		$155K Buy
4,483
+1,392
+45% +$54.6K ﹤0.01% 2495
2024
Q2 		$90.6K Buy
+3,091
New +$122K ﹤0.01% 2604

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's STRO Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 4,900 shares — an estimated $31.9K sold.

Mirae Asset Global ETFs Holdings first reported a position in STRO in Q2 2024 and held it in 4 quarters. The position peaked at $155K in Q3 2024. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 4,900 Sutro Biopharma shares in Q2 2025, an estimated $31.9K.
  • Mirae Asset Global ETFs Holdings first reported a position in Sutro Biopharma in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Sutro Biopharma position peaked at $155K in Q3 2024.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.